MNPR Competitors & Alternatives
Compare Monopar Therapeutics Inc with similar stocks in the same industry
Biotechnology
MNPR
Main Stock$85.96
Tradestie Score
58
Market Cap
$522.78M
Analyst Upside
+31.0%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$93.42
|
$492.21M | - | 53 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$42.07
|
$474.20M | 26.8 | 59 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$8.93
|
$468.01M | - | 58 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$21.12
|
$463.20M | - | 56 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$8.95
|
$457.09M | - | 62 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$5.59
|
$454.29M | - | 57 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$19.63
|
$448.32M | - | 65 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$24.34
|
$422.50M | - | 56 | Compare |
More MNPR Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry